EP Lab

This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.

News | Catheter

Sterotaxis' Catheter Receives FDA Clearance

July 28, 2025 — Stereotaxis, a provider of surgical robotics for minimally invasive endovascular intervention, has ...

July 28, 2025

News | Cardiac Imaging

ASRT Releases Latest Radiologic Sciences Staffing and Workplace Survey

July 25, 2025 — Data in recent staffing surveys from the American Society of Radiologic Technologists show that vacancy ...

July 25, 2025

News | Cardiac Resynchronization Therapy Devices (CRT)

TCAI Implants FDA-approved Leadless System to Provide Cardiac Resynchronization Therapy

July 21, 2025. — Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center ...

July 21, 2025

Sponsored Content

Several wearable, less-obtrusive ECG monitors fhave been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device.

Feature | ECG

Moving Beyond Holter ECG: The Rise in Next Generation Technology

When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The newer ECG devices we have now are so much less cumbersome. It’s like wearing a Band-Aid versus carrying a bulky device,” said the Greenwood, Mississippi internist. “My patients prefer the more comfortable, wire-free form factor, and the quality is as good as, or better, than the Holter,” continued Boler. “Plus, my patient compliance has increased. With the Holter, the leads sometimes come off. The patient may think the device isn’t working, so they take it off and we have to restart the process.”

February 19, 2020

FDA Approves J&J Medtech's Updated Varipulse Platform Irrigation Rate

News

J&J Medtech's Updated Varipulse Platform Irrigation Rate Gets FDA Approval

July 14, 2025  –  Johnson & Johnson MedTech has announced U.S. Food and Drug Administration (FDA) approval of an update ...

July 14, 2025

News | Catheters

Stereotaxis Pubishes First Clinical Results from MAGiC Catheter Study

July 1, 2025 — Stereotaxis, a provider of surgical robotics for minimally invasive endovascular intervention, has ...

July 10, 2025

News

Study Provides Insight into Mysterious Migraine Symptoms Following Cardiovascular Procedures

July 7, 2025 — Catheter ablation is a minimally invasive treatment for abnormal heart rhythms. It is often successful in ...

July 09, 2025

Sponsored Content

Most professional athletes participate in cardiovascular screening to identify often-asymptomatic heart disorders, but the debate continues on whether to mandate ECGs as part of pre-participation screening for student athletes. Photo courtesy of Play for Patrick.

Feature | Sudden Cardiac Arrest

As Interpretation Criteria Evolve, False Positive Athlete ECG Screening Rates Can Decrease

Sudden cardiac death (SCD) is the leading medical cause of death in young athletes and its impact is consistent worldwide. Most professional athletes in the United States are required to take part in comprehensive cardiovascular screening programs to identify often-asymptomatic congenital or inherited heart disorders, and other cardiac risk factors. There remains a debate however, whether to mandate ECGs as part of pre-participation screening programs for student athletes at the collegiate and high school levels or even at younger ages.

October 16, 2018